can type 1 diabetics use glp-1 Receptor Agonists as Treatments for 2 Diabetes GLP-1s for Type 1 Diabetes?

Regulatory approval data, clinical safety studies, GRAS (Generally Recognized as Safe) notifications, New Dietary Ingredient (NDI) filings, production statistics, import-export trade data, antioxidant research studies, demographic health trends, and market landscape analysis for glutathione across nutraceuticals, cosmetics, pharmaceuticals, and food and beverage applications were all gathered from these sources

The development of more potent and selective glutaminase inhibitors and effective delivery strategies remains an active area of research

Pickart LR

There is no fixed, validated timeline because the product is unregulated and individual responses differ